We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock

Delisted

CTIC was delisted on the 23rd of June, 2023.

56 hedge funds and large institutions have $160M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

20% more capital invested

Capital invested by funds: $133M → $160M (+$26.5M)

12% more funds holding

Funds holding: 5056 (+6)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

13% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 15

33% less call options, than puts

Call options by funds: $287K | Put options by funds: $431K

Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
0.98%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
13
Increased
13
Reduced
15
Closed
7
Calls
$287K
Puts
$431K
Net Calls
-$144K
Net Calls Change
-$647K
Name Holding Trade Value Shares
Change
Change in
Stake
OSAM
51
O'Shaughnessy Asset Management
Connecticut
$1K -$232 -85 -21%
Squarepoint
52
Squarepoint
New York
-$181K -72,325 Closed
OQS
53
Occudo Quantitative Strategies
Florida
-$139K -55,555 Closed
Goldman Sachs
54
Goldman Sachs
New York
-$104K -41,558 Closed
QSS
55
Quantitative Systematic Strategies
Florida
-$64K -25,686 Closed
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
+$8 +3 +7%